MCL1 and non-small cell lung carcinoma: Osim inhibits ERK‐dependent Mcl‐1 phosphorylation and facilitates Mcl‐1 degradation, leading to Mcl‐1 reduction in sensitive EGFR‐mutant NSCLC cells, as we have recently demonstrated (Shi et al., 2017).